Resources

Clinical Studies & Peer-Reviewed Research

The following clinical studies and peer-reviewed research demonstrate the safety and efficacy around bioidentical hormone replacement therapy, testosterone replacement therapy, estrogen replacement therapy, and more related topics. The safety and efficacy of our treatment approach relies on thorough research, and these studies show the impact such therapies can have on your quality of life.

3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial

3,3′-Diindolylmethane protects cardiomyocytes from LPS-induced inflammatory response and apoptosis

70 Years of Levothyroxine

Activation and inactivation of thyroid hormone by deiodinases: Local action with general consequences

Anti-Cancer and Other Biological Effects of a Dietary Compound 3,3ʹ-Diindolylmethane Supplementation: A Systematic Review of Human Clinical Trials

Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus

Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.

Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy.

Alzheimer’s disease: review of hormone therapy trials and implications for treatment and prevention after menopause

Study of adverse outcomes in women using testosterone therapy.

Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)

Testosterone therapy in women: Myths and misconceptions

Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer

Progress in neuroprotective strategies for preventing epilepsy

The Benefits of Subcutaneous Delivery of Pelletized Drug Formulations Using a Novel Access and Insertion Device:

The safety of postmenopausal testosterone therapy